Geranylgeranylacetone, an anti-ulcer drug, stimulates hexosamine production in a rat gastric mucosal cell line through binding to a specific cytosolic protein

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 8, 1998, Pages 809-815

  Hassan, Sazzad ^a   Kinoshita, Yoshikazu ^b   Okada, Akihiko ^c   Maekawa, Toru ^c   Fukui, Hirokazu ^c   Chiba, Tsutomu ^c  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytosolic protein; GGA; Hexosamine; RGM 1

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; HEXOSAMINE; TEPRENONE;

ANIMAL CELL; ARTICLE; DNA SYNTHESIS; DRUG EFFECT; DRUG PROTEIN BINDING; IMMUNOBLOTTING; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STOMACH MUCOSA;

EID: 0031829911     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00737.x     Document Type: Article

References (31)

1. Murakami M, Oketani K, Fukisaki H, Wakabayashi T, Ohgo T. Antiulcer effect of geranylgeranylacetone, a new acyclic polyisoprenoid on experimentally induced gastric and duodenal ulcers in rats. Arzneimittelforschung 1981; 31: 799-804.
2. Shirakabe H, Takemoto T, Kobayashi K et al. Clinical evaluation of teprenone, a mucosal protective agent, in the treatment of patients with gastric ulcers: A nationwide, multicenter clinical study. Clin. Ther. 1995; 17: 924-35.
3. Fujimoto M, Yamanaka T, Bessho M, Igarashi T. Effect of geranylgeranylacetone on gastrointestinal secretion in rats. Eur. J. Pharmacol. 1982; 77: 113-18.
4. Terano A, Shiga J, Hiraishi H, Ota S, Sugimoto T. Proteclive action of tetraprenylacetone against ethanol-induced damage in rat gastric mucosa. Digestion 1986; 35: 182-3.
5. Kunisaki C, Sugiyama M. Effect of teprenone on acute gastric mucosal lesions induced by cold-restraint stress. Digestion 1992; 53: 45-53.
6. Bilski J, Murty VLN, Nadziejko C, Aono M, Moriga M, Slomiaey BL. Protection against alcohol-induced gastric mucosal injury by geranylgeranylacetone: Effect of indomethacin. Digestion 1988; 41: 22-33.
7. Terano A, Hiraishi H, Ota S, Sugimoto T. Geranylgeranylacetone, a novel anti-ulcer drug stimulates mucus synthesis and secretion in rat gastric cultured cells. Digestion 1986; 33: 206-10.
8. Bilski J, Sarosiek J, Murty VL et al. Enhancement of the lipid content and physical properties of gastric mucus by geranylgeranylacetone. Biochem. Pharmacol. 1987; 36: 4059-65.
9. Itoh Y, Suzuki K, Matsubara M, Takeyama N, Kitazawa Y, Tanaka T. Changes in gastric mucosal content of adenosine, xanthine and hypoxanthine induced by restrained water immersion stress: Antiulcer effect of tetraprenylacetone. Digestion 1991; 48: 25-33.
10. Morimoto Y, Shimohara K, Oshima S, Sukamoto T. Effect of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine. Jpn J. Pharmacol. 1991; 57: 495-505.
11. Tanoue K, Tarnawski AS, Kishihara F et al. Effect of teprenone on portal hypertensive gastric mucosa. Digestion 1996; 57: 35-40.
12. Sakai M, Sagara K, Fujiyama S, Murata H, Sato T. Gastric mucosal hexosamine content in various liver diseases. Hepatogastroentcrology 1991; 38: 302-6.
13. Hassan S, Kinoshita Y, Min D et al. Presence of prostaglandin EP4 receptor gene expression in a rat gastric mucosal cell line. Digestion 1996; 57: 196-200.
14. Okada A, Kinoshita Y, Maekawa T et al. Erythropoietin stimulates proliferation of rat-cultured gastric mucosal cells. Digestion 1996; 57: 328-32.
15. Kinoshita Y, Nakata H, Hassan S et al. Gene expression of keratinocyte and hepatocyte growth factors during healing of rat gastric mucosal lesions. Gastroenterology 1995; 109: 1068-77.
16. Neuhaus OW, Letzring M. Determination of hexosamine in conjunction with electrophoresis on starch. Anal. Chem. 1957; 267: 1230-3.
17. Chiba T, Yamaguchi A, Yamatani T et al. Calcitonin generelated peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol. 1989; 256: E331-5.
18. Chiba T, Sugano K, Park J, Yamada T. Potential mediation of somatostatin secretion from canine fundic D-cells by protein kinase C. Am. J. Physiol. 1987; 253: G62-7.
19. Yamatani T, Yamaguchi A, Nakamura A et al. Activation of PKC inhibits NaF-induced inositol phospholipid turnover in rat insulinoma cells. Am. J. Physiol. 1990; 259: E73-9.
20. Hassan S, Kinoshita Y, Kawanami C et al. Expression of the proto-oncogene c-kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines. Dig. Dis. Sci. 1998; 43: 8-14.
21. Ishizuka S, Oshida JI, Tsuruta H, Norman AW. The stereo-chemical configuration of the natural 1a, 25-dihydroxy-vitamin D,-26,23-lactone. Arch. Bioehem. Biaphys. 1985; 242: 82-9.
22. Sato N, Ota M, Obara K. Presence of binding component(s) for testosterone in rat liver cytosol. Endocrinol. Jpn 1980; 27: 315-19.
23. Kinoshita Y, Fukase M, Yamatani T et al. Possible involvement of inositol phosphates and calmodulin in calcitonin-induced stimulation of phosphate transport in LLC-PKI cells. Biochem. Biophys. Res. Commun. 1987; 144: 741-8.
24. Watanabe S, Hirose M, Wang XN et al. Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells. Biochem. Biophys. Res. Commun. 1994; 199: 1453-60.
25. Nakamura N, Shidoji Y, Moriwaki H, Muto Y. Apoptosis in human hepatoma cell line induced by 4:5-didehydrogeranylgeranoic acid (acyclic retinoid) via down regulation of transforming growth factor-alpha. Biochem. Biophys. Res. Commun. 1996; 219: 100-4.
26. Araki H, Shidoji Y, Morikawa H, Muto Y. Retinoid agonist activities of synthetic geranylgeranoic acid derivatives. Biochem. Biophys. Res. Commun. 1995; 209: 66-72.
27. Sakai I, Tanaka T, Osawa S, Hashimoto S, Nakaya K. Geranylgeranylacetone used as an antiulcer agent is a potent inducer of differentiation of various myeloid leukemia cell lines. Biochem. Biophys. Res. Commun. 1993; 191: 873-9.
28. Bashor MM, Chytil F. Cellular retinoid-binding protein. Biochem. Biophys. Acta 1975; 411: 87-96.
29. Sani BP, Corbett TH. Retinoic acid-binding protein in normal tissues and experimental tumors. Cancer Res. 1977; 37: 209-13.
30. Rosewicz S, Stier U, Brembeck F et al. Retinoids: Effects on growth, differentiation and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroemerology 1995; 109: 1646-60.
31. Pefkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444-50.